MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-03-0003365
Medicita Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.04 Cr
▲ 30% YoY
Net profit · FY 2024
₹98.78 Lakh
Net margin 5.8%
EBITDA · FY 2024
₹1.58 Cr
EBITDA margin 9.3%
Authorised capital
₹11 Lakh
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Open charges
₹4.22 Cr
Satisfied ₹8.98 Lakh
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Medicita Pharma Private Limited
Data last updated:
Medicita Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC304318. Its GSTIN is 07AAKCM4978L1ZO (Delhi).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Ajay Kumar and Arun Kumar Saraswat.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot 307 Fie Patpadganj, Industrial Area, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.04 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹98.78 Lakh (net margin 5.8%) and EBITDA of ₹1.58 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years and 50% over five years.
As per MCA filings, the company has open charges of ₹4.22 Cr and satisfied charges of ₹8.98 Lakh on record.
Medicita Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0003365). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicitapharma.com.
Company Details of Medicita Pharma Private Limited
CIN U74999DL2016PTC304318
Registration Number 304318
Incorporation Date 11 August 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-03-0003365
Key People
Ajay Kumar Director Arun Kumar Saraswat Director Recognitions & Rankings of Medicita Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot 307 Fie Patpadganj, Industrial Area, New Delhi, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Medicita Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Medicita Pharma Private Limited
The main business activity of Medicita Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medicita Pharma Private Limited FY 2024 filings available
Medicita Pharma Private Limited reported revenue of ₹17.04 Cr (up 30% YoY) for FY 2024.
Revenue · FY 2024
₹17.04 Cr ▲ 30%
Net profit · FY 2024
₹98.78 Lakh margin 5.8%
EBITDA · FY 2024
₹1.58 Cr margin 9.3%
Compounded Annual Growth Rate (CAGR) of Medicita Pharma Private Limited
Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 104%
5 years · compounded
▲ 50%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 85%
5 years · compounded
▲ 45%
Revenue has grown at a compounded annual rate (CAGR) of 50% over five years, including 30% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medicita Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.58 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹98.78 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medicita Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medicita Pharma are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Medicita Pharma Private Limited
Medicita Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Also directs: Seanan Laboratories Private Limited | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
| Arun Kumar Saraswat Also directs: Seanan Laboratories Private Limited, Commbiio Foundation | Director | 27 Apr 2022 | 4 Years 5 Months | Current |
Peer Comparison of Medicita Pharma Private Limited
Medicita Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brillcomp Services Private Limited | ₹17.15 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
| Manchanda Interiors Private Limited | ₹17.15 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Agra, Uttar Pradesh, India |
| Indoma Marine Private Limited | ₹17.13 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Guwahati, Assam, India |
| Kaushal Healthcare Private Limited | ₹17.1 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Kolkata, West Bengal, India |
| Nagpur Agencies Private Limited | ₹17.1 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Nagpur, Maharashtra, India |
| Medicita Pharma Private Limited this company | ₹17.04 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | New Delhi, Delhi, India |
| Unibiotic India Private Limited | ₹17.03 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Shri Imaging and X-Ray Films Private Limited | ₹17 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Olympus Therapeutics Private Limited | ₹16.9 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Chennai, Tamil Nadu, India |
| Starlex Health Services and Products Private Limited | ₹16.89 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Perinthalmanna, Kerala, India |
| Pharmacheck Impex Private Limited | ₹16.87 Cr (FY 2025) | •••• | •••• | 63.0% | •••• | Nagpur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Medicita Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medicita Pharma Private Limited
Medicita Pharma Private Limited is audited by AGARWAL CHIRAG & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AGARWAL CHIRAG & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Medicita Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medicita Pharma Private Limited
Open charges
₹4.22 Cr
Satisfied charges
₹8.98 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2024 | State Bank of India | ₹22 Lakh | Open |
| 11 Mar 2024 | State Bank of India | ₹4 Cr | Open |
| 19 Apr 2024 | State Bank of India | ₹8.98 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Medicita Pharma Private Limited
Employment history and EPFO contributions of people linked to Medicita Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medicita Pharma Private Limited
Medicita Pharma Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Arun Kumar Saraswat ceased to be Additional Director on 30 Sep 2022.
Charges
A charge registered on 19 Apr 2024 via Charge ID 100909345 with State Bank Of India was fully satisfied on 23 Oct 2024.
Charges
A charge with State Bank Of India amounted to Rs. 22.00 Lakh with Charge ID 100997041 was registered on 18 Oct 2024.
AGM
Medicita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 8.98 Lakh with Charge ID 100909345 was registered on 19 Apr 2024.
Filing
Medicita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with State Bank Of India amounted to Rs. 400.00 Lakh with Charge ID 100894388 was registered on 11 Mar 2024.
Ceased
Arun Kumar Saraswat ceased to be Additional Director.
Appointed
Arun Kumar Saraswat was appointed as Director.
Ceased
Durgesh Sarswat ceased to be Director.
Ceased
Jamshed Alam Ansari ceased to be Director.
Appointed
Ajay Kumar was appointed as Director.
Incorporation
11 Aug 2016
Medicita Pharma Private Limited was registered on 11 Aug 2016 with Roc Delhi & aged 10 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Medicita Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medicita Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medicita Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medicita Pharma Private Limited
Medicita Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCM4978L1ZO | Delhi | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medicita Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicita Pharma Private Limited
Medicita Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 August 2016 (10+ years old) and is registered under CIN U74999DL2016PTC304318.
Medicita Pharma reported revenue of ₹17.04 Cr for FY 2024 (up 30% YoY).
Medicita Pharma has 2 current directors:
- Ajay Kumar - Director
- Arun Kumar Saraswat - Director
Medicita Pharma reported a net profit of ₹98.78 Lakh (net margin 5.8%) and EBITDA of ₹1.58 Cr (EBITDA margin 9.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medicita Pharma is 104% over three years and 50% over five years. In the latest year (FY 2024) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medicita Pharma is 07AAKCM4978L1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of Medicita Pharma is U74999DL2016PTC304318. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicita Pharma was incorporated on 11 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medicita Pharma by revenue are Brillcomp Services Private Limited, Manchanda Interiors Private Limited, Indoma Marine Private Limited, Kaushal Healthcare Private Limited, Nagpur Agencies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Arun Kumar Saraswat ceased to be Additional Director on 30 Sep 2022. Arun Kumar Saraswat was appointed as Director on 27 Apr 2022. Durgesh Sarswat ceased to be Director on 27 Apr 2022. Medicita Pharma has 5 board changes on record in total.
Yes, Medicita Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-03-0003365).